Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Pagliuca

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
International Journal of Hematologic Oncology|August 31, 2019
The importance of early intervention in the treatment of hepatic veno-occlusive diseaseAntonio Pagliuca
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
High fever occurring 4 to 5 days post-transplant of haploidentical bone marrow or peripheral blood stem cells after reduced-intensity conditioning associated with the use of post-transplant cyclophosphamide as prophylaxis for graft-versus-host diseasePaul O'Donnell, Kavita Raj, Antonio Pagliuca
Hematology (Amsterdam, Netherlands)|December 12, 2002
Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?Aloysius Y L Ho, Antonio Pagliuca
The New England Journal of Medicine|January 12, 2022
Aspergillus InfectionsM Mansour Ceesay, Varun Mehra, Antonio Pagliuca
Clinical Medicine (London, England)|August 4, 2018
Cancer immunotherapy with CAR-T cells - behold the futureCharlotte Graham, Rebecca Hewitson, Antonio Pagliuca, et al.
Infectious Diseases (London, England)|November 1, 2024
Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies nowAntonio Pagliuca, Sundeep Kaul, Carl S Goodyear, et al.
British Journal of Hospital Medicine (London, England : 2005)|September 6, 2022
Optimising care for UK patients with acute myeloid leukaemiaAntonio Pagliuca, Asim Khwaja, Richard Dillon, et al.
British Journal of Haematology|September 27, 2003
Guidelines on the use of colony-stimulating factors in haematological malignanciesAntonio Pagliuca, Patrick A Carrington, Ruth Pettengell, et al.
Haematologica|June 8, 2006
Life-threatening motor neurotoxicity in association with bortezomibSunil Gupta, Antonio Pagliuca, Steve Devereux, et al.
Haematologica|August 23, 2006
Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasoneKarthik Ramasamy, ZiYi Lim, Antonio Pagliuca, et al.
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
International Journal of Hematologic Oncology|August 31, 2019
The importance of early intervention in the treatment of hepatic veno-occlusive diseaseAntonio Pagliuca
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
High fever occurring 4 to 5 days post-transplant of haploidentical bone marrow or peripheral blood stem cells after reduced-intensity conditioning associated with the use of post-transplant cyclophosphamide as prophylaxis for graft-versus-host diseasePaul O'Donnell, Kavita Raj, Antonio Pagliuca
Hematology (Amsterdam, Netherlands)|December 12, 2002
Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?Aloysius Y L Ho, Antonio Pagliuca
The New England Journal of Medicine|January 12, 2022
Aspergillus InfectionsM Mansour Ceesay, Varun Mehra, Antonio Pagliuca
Clinical Medicine (London, England)|August 4, 2018
Cancer immunotherapy with CAR-T cells - behold the futureCharlotte Graham, Rebecca Hewitson, Antonio Pagliuca, et al.
Infectious Diseases (London, England)|November 1, 2024
Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies nowAntonio Pagliuca, Sundeep Kaul, Carl S Goodyear, et al.
British Journal of Hospital Medicine (London, England : 2005)|September 6, 2022
Optimising care for UK patients with acute myeloid leukaemiaAntonio Pagliuca, Asim Khwaja, Richard Dillon, et al.
British Journal of Haematology|September 27, 2003
Guidelines on the use of colony-stimulating factors in haematological malignanciesAntonio Pagliuca, Patrick A Carrington, Ruth Pettengell, et al.
Haematologica|June 8, 2006
Life-threatening motor neurotoxicity in association with bortezomibSunil Gupta, Antonio Pagliuca, Steve Devereux, et al.
Haematologica|August 23, 2006
Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasoneKarthik Ramasamy, ZiYi Lim, Antonio Pagliuca, et al.
Pageof 12